Jeffrey W.-D. Foy

Impurities in Oligonucleotide Drug Substances and Drug Products

Daniel C. Capaldi, Andy Teasdale, Scott P. Henry et al. · Nucleic Acid Therapeutics · 2017 · 125 citations

White Paper, Molecular Biology, Nucleic Acid Chemistry +17

Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection

Elisabeth C.R. Solano, Douglas J. Kornbrust, Amber Beaudry et al. · Nucleic Acid Therapeutics · 2014 · 86 citations

Small Interfering Rna, Ocular Disease, Vitreous Body +14

Toxicological and Pharmacokinetic Properties of Chemically Modified siRNAs Targeting p53 RNA Following Intravenous Administration

James D. Thompson, Douglas J. Kornbrust, Jeffrey W.-D. Foy et al. · Nucleic Acid Therapeutics · 2012 · 84 citations

Immunology, Cell Death, Pharmacotherapy +17

A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-“tar” cigarettes

Jeffrey W.-D. Foy, Betsy Bombick, David W. Bombick et al. · Food and Chemical Toxicology · 2003 · 53 citations

Tobacco Control, Tobacco Use, Medicine +7

Local Tolerance and Systemic Safety of Pegaptanib Sodium in the Dog and Rabbit

Jeffrey W.-D. Foy, Kay D. Rittenhouse, Marlene Modi et al. · Journal of Ocular Pharmacology and Therapeutics · 2007 · 52 citations